Capecitabine Pill

DRUG2 trials

Sponsors

Peter MacCallum Cancer Centre, Australia, University of Alabama at Birmingham

Conditions

Metastatic Breast CancerRectal Cancer

Phase 2

Avelumab With Chemoradiation in Locally Advanced Rectal Cancer

CompletedNCT03299660

Peter MacCallum Cancer Centre, AustraliaRectal Cancer

Start: 2018-04-30End: 2023-02-28Updated: 2023-03-16

Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer

RecruitingNCT06105684

University of Alabama at BirminghamMetastatic Breast Cancer

Start: 2025-02-14End: 2028-06-30Target: 40Updated: 2026-01-07

Related Papers

Abstract P3-10-18: Phase II Single Arm Trial of Low Dose Capecitabine in Patients with Advanced Breast Cancer (NCT06105684)

Clinical Cancer Research2025-06-13

The Ave-Rec trial: Phase II trial of PD-L1/PD-1 blockade with avelumab plus chemoradiotherapy for locally advanced resectable T3B-4/N1-2 rectal cancer—Toxicity and interim efficacy data.

Journal of Clinical Oncology2023-06-012 citations

Phase II trial PD-L1/PD-1 blockade avelumab with chemoradiotherapy for locally advanced resectable T3B-4/N1-2 rectal cancer: The Ave-Rec trial.

Journal of Clinical Oncology2019-05-205 citations